Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HUM
STRONG BUYFLAGHumana Inc. · Healthcare · United States · $46.7B · Avg Vol: $558M/d
Humana has strong momentum at M79 with a buyback on file, but value at V47 is below the calibrated floor and quality Q55 is modest, so stage one fails, consistent with the Mexican line flagged earlier in this run.
COMPANY DESCRIPTION
Humana Inc. is a leading U.S. health and well-being company focused on integrated health care plans, particularly for Medicare and Medicaid beneficiaries. The company's extensive clinical care services and strong focus on value-based care models differentiate it in the competitive health insurance landscape. Humana's significant market share in the growing Medicare Advantage sector provides a stable and expanding revenue base.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92.9B | 106.4B | 117.8B | 129.7B | 11.8% | 137.2B | 162.3B | 169.9B | 14.5% |
| EPS | 22.20 | 20.09 | 10.01 | 9.87 | -23.7% | 9.32 | 5.16 | 9.23 | -3.3% |
| Shares | 125.0M | 122.2M | 120.6M | 120.6M | -3.5% | 120.1M | — | — | — |
| Debt | 11.1B | 11.7B | 11.7B | 12.4B | 3.6% | 14.4B | — | — | — |
| Equity | 15.3B | 16.3B | 16.4B | 17.7B | 4.9% | — | — | — | — |
| Op CF | 4.6B | 4.0B | 3.0B | 921.0M | -41.4% | 1.8B | — | — | — |
| Inv CF | -1.0B | -3.5B | -3.0B | 2.3B | — | — | — | — | — |
| Fin CF | -1.9B | -856.0M | -2.5B | -1.2B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HUM are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HUM | Humana Inc.(you) | $46.7B | 86 | STRONG BUY |
| CNC | Centene Corporation | $31.3B | 92 | STRONG BUY |
| ELV | Elevance Health, Inc. | $81.9B | 94 | STRONG BUY |
| CI | The Cigna Group | $76.6B | 97 | STRONG BUY |
| CVS | CVS Health Corporation | $137.5B | 90 | STRONG BUY |
| OSCR | Oscar Health, Inc. | $8.5B | 88 | STRONG BUY |
| MOH | Molina Healthcare, Inc. | $10.3B | 77 | BUY |
| UNH | UnitedHealth Group Incorporated | $382.1B | 91 | STRONG BUY |
| PGNY | Progyny, Inc. | $2.4B | 97 | STRONG BUY |
| CLOV | Clover Health Investments, Corp. | $2.3B | 73 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.9%